Novartis Cuts 150 Jobs As it Shifts Focus of Shanghai Facility to Drug Development

Three years after Novartis opened a $1 billion research & development facility in Shanghai, the company is shifting the focus of the site from drug discovery to commercial development.

As a result of the pivot, about 150 early drug discovery research staff will lose their jobs. However, in the long run, Novartis plans to add more than 300 jobs to the facility.